MSA
NKTR icon

Mason Street Advisors’s Nektar Therapeutics NKTR Stock Holding History

Mason Street Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,383
Closed -$1.65M – 726
2020
Q3 		$1.59M Sell
6,383
-120
-2% -$37.7K 0.03% 630
2020
Q2 		$2.26M Buy
6,503
+265
+4% +$82.7K 0.05% 459
2020
Q1 		$1.67M Hold
6,238
– – 0.04% 517
2019
Q4 		$2.02M Buy
6,238
+4,573
+275% +$1.33M 0.04% 594
2019
Q3 		$455K Buy
1,665
+8
+0.5% +$2.93K 0.01% 1125
2019
Q2 		$884K Buy
1,657
+1
+0.1% +$501 0.02% 903
2019
Q1 		$835K Buy
1,656
+29
+2% +$17.2K 0.02% 957
2018
Q4 		$802K Buy
1,627
+11
+0.7% +$6.64K 0.02% 877
2018
Q3 		$1.48M Buy
1,616
+109
+7% +$93K 0.03% 731
2018
Q2 		$1.1M Buy
1,507
+13
+0.9% +$15K 0.02% 838
2018
Q1 		$2.38M Sell
1,494
-1,236
-45% -$1.59M 0.05% 436
2017
Q4 		$2.45M Buy
2,730
+90
+3% +$53.2K 0.05% 417
2017
Q3 		$950K Buy
2,640
+89
+3% +$27.8K 0.02% 853
2017
Q2 		$748K Buy
2,551
+153
+6% +$44.2K 0.02% 890
2017
Q1 		$844K Buy
2,398
+172
+8% +$38.7K 0.02% 862
2016
Q4 		$410K Buy
2,226
+349
+19% +$71K 0.01% 1020
2016
Q3 		$484K Buy
1,877
+101
+6% +$26K 0.01% 942
2016
Q2 		$379K Buy
1,776
+165
+10% +$36.9K 0.01% 978
2016
Q1 		$332K Buy
1,611
+177
+12% +$34K 0.01% 982
2015
Q4 		$362K Buy
1,434
+134
+10% +$27.6K 0.01% 946
2015
Q3 		$214K Buy
1,300
+177
+16% +$31.3K 0.01% 1057
2015
Q2 		$211K Buy
+1,123
New +$193K 0.01% 1066

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Mason Street Advisors's NKTR Position: Q4 2020 in Review

Mason Street Advisors sold out of Nektar Therapeutics (NKTR) in Q4 2020, closing a stake of 6,383 shares — an estimated $1.65M sold.

Mason Street Advisors first reported a position in NKTR in Q2 2015 and held it in 22 quarters. The position peaked at $2.45M in Q4 2017. 245 funds tracked by Wall St. Rank hold NKTR as of Q4 2020.

  • Mason Street Advisors reported no remaining Nektar Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Mason Street Advisors sold 6,383 Nektar Therapeutics shares in Q4 2020, an estimated $1.65M.
  • Mason Street Advisors first reported a position in Nektar Therapeutics in Q2 2015 and held it in 22 quarters.
  • Mason Street Advisors's Nektar Therapeutics position peaked at $2.45M in Q4 2017.
  • 245 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2020.

Based on Mason Street Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.